Glen Hooker, MD
Colon & Rectal Surgery · Fort Worth, TXNPI 1043235864
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 84.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $5,669 and has fallen 93.4% since, to $373 in 2025.
Across 77 payments — averaging $140.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Cook Biotech Incorporated$442
- Medtronic$297
- Micro-tech Endoscopy USA, Inc.$182
- Acera Surgical, Inc.$102
- Axonics, Inc.$73
- plus $582 from 17 others
What the payments were for
- Travel & lodging$2,51423%
- Food & beverage$2,08619%
- Education$6,25058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 32 | $9,172 |
| Cook Biotech Incorporated | 2 | $442 |
| Medtronic(2 entities) | 7 | $297 |
| Micro-tech Endoscopy USA, Inc. | 1 | $182 |
| Acera Surgical, Inc. | 4 | $102 |
| Axonics, Inc. | 4 | $73 |
| Baxter Healthcare | 3 | $70 |
| Johnson & Johnson | 2 | $52 |
| Ferring Pharmaceuticals Inc. | 2 | $48 |
| Innovation Technologies Inc | 1 | $46 |
| Shire North American Group Inc | 2 | $43 |
| THD America, Inc. | 3 | $40 |
| Braintree Laboratories, Inc. | 2 | $37 |
| TELA Bio, Inc. | 2 | $35 |
| Covidien LP | 2 | $33 |
| Activ Surgical, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Davol Inc. | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $25 |
| Acell, Inc. | 1 | $19 |
| Concordia Pharmaceuticals Inc. | 1 | $16 |
| Polynovo North America LLC | 1 | $15 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,463
- DAVINCI XI$1,000
- BIODESIGN$277
- All Products$182
- Oasis$165
- Signia$124
How this compares
$10,849 in reported general payments places this provider in the 70th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $268 |
| Ondansetron OdtOndansetron | 13 | $100 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Fort Worth
- Farshid AraghizadehFort Worth$181K
- Nezar JrebiFort Worth$69K
- Paul SenterFort Worth$21K
- Jason AllenFort Worth$20K
- Bethany MaloneFort Worth$11K
- Yu-Hsin LinFort Worth$10K
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.